[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]. Klotz L, Berthele A, Brück W, Chan A, Flachenecker P, Gold R, Haghikia A, Hellwig K, Hemmer B, Hohlfeld R, et al. Nervenarzt. 2016 Feb 29. PMID: 26927677. Abstract CommentRecommendBookmarkWatch